| |
|
|
|
|
|
|
|||
|
Blood, 15 October 2007, Vol. 110, No. 8, pp. 3049-3055. Prepublished online as a Blood First Edition Paper on July 16, 2007; DOI 10.1182/blood-2007-02-074393.
RED CELLS Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice1 Department of Research, Experimental Hematology, University Hospital Basel, Basel, Switzerland; 2 Department of Pathology, University Hospital Basel, Basel, Switzerland, and Department of Health Sciences, University of Molise, Campobasso, Italy; 3 Department of Clinical-Biological Sciences, Laboratory of Pediatric Immunology, University of Basel and Basel University Children's Hospital (UKBB), Basel, Switzerland; 4 Mammalian Genetics Section, Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD
The tumor suppressor Smad4 mediates signaling by the transforming growth factor beta (TGF-ß) superfamily of ligands. Previous studies showed that several TGF-ß family members exert important functions in hematopoiesis. Here, we studied the role of Smad4 in adult murine hematopoiesis using the inducible Mx-Cre/loxP system. Mice with homozygous Smad4 deletion (Smad4
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||